253 results on '"Pernod, Gilles"'
Search Results
2. Venous recanalisation in the setting of post-thrombotic syndrome: An expert consensus from the French Society of Vascular Medicine (SFMV) and the French Society of Cardiovascular Imaging and Interventional Radiology (SFICV)
3. Update on the diagnosis of recurrence of lower limb deep vein thrombosis. A Consensus statement of the French Society for Vascular Medicine (SFMV)
4. Traduction et republication de : « Événements thromboemboliques artériels liés au cancer »
5. Update About the Management of Low-Density Lipoprotein Cholesterol and Hypertriglyceridemia in Lower Extremity Peripheral Artery Disease Patients: Consensus of the French Society of Vascular Medicine and the French Society for Vascular and Endovascular Surgery
6. Outpatient management of cancer-associated pulmonary embolism: A post-hoc analysis from the HOME-PE trial
7. Cancer-related arterial thromboembolic events
8. Management of venous thromboembolic disease in patients with malignant brain tumours
9. Frequency and predictors for chronic thromboembolic pulmonary hypertension after a first unprovoked pulmonary embolism: Results from PADIS studies
10. Comparative evaluation of socioeconomic insecurity in peripheral and coronary artery disease patients
11. Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin
12. Patients treated with vitamin K oral anticoagulants in family practice: a new approach to bleeding risk assessment. An ancillary study by the CACAO prospective general practice cohort.
13. Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism: A Randomized Trial
14. Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin
15. Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination
16. Compliance with Early Long-Term Prophylaxis Guidelines for Severe Hemophilia A
17. Disparities Between International Guidelines (AHA/ESC/ESVS/ESVM/SVS) Concerning Lower Extremity Arterial Disease: Consensus of the French Society of Vascular Medicine (SFMV) and the French Society for Vascular and Endovascular Surgery (SCVE)
18. Traduction et republication de : « Événements thromboemboliques artériels liés au cancer ».
19. Epidemiology and 3‐year outcomes of combined oral contraceptive–associated distal deep vein thrombosis
20. Evaluation of Venous Thromboembolism Recurrence Scores in an Unprovoked Pulmonary Embolism Population: A Post-hoc Analysis of the PADIS-PE trial
21. Evaluation of the predictive value of the bleeding prediction score VTE‐BLEED for recurrent venous thromboembolism
22. HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome
23. Position du GIHP sur les tests viscoélastiques : quelle place pour quelle indication en situation hémorragique ?
24. Long-term outcomes of isolated superficial vein thrombosis in patients with active cancer
25. Management of bleeding and emergency invasive procedures in patients on dabigatran: Updated guidelines from the French Working Group on Perioperative Haemostasis (GIHP) – September 2016
26. Diagnosis of deep vein thrombosis recurrence: Ultrasound criteria
27. Endovascular Treatment of Post-thrombotic Venous Ilio-Femoral Occlusions: Prognostic Value of Venous Lesions Caudal to the Common Femoral Vein
28. Impact of an educational program on the quality of life of patients with lymphedema: A preliminary evaluation
29. Anaemia as an independent key risk factor for major haemorrhage in patients treated with vitamin K antagonists: Results of the SCORE prospective cohort
30. Oral anticoagulant safety in family practice: prognostic accuracy of Bleeding Risk Scores (from the CACAO study).
31. Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism: comment
32. Gestion péri-opératoire des nouveaux anticoagulants oraux
33. Evaluation of a mobile electronic assistant to aid in fluindione prescription: The INRPlus cluster randomized trial
34. Validation of the STA-Liatest DDi assay for exclusion of proximal deep vein thrombosis according to the latest Clinical and Laboratory Standards Institute/Food and Drug Administration guideline: results of a multicenter management study
35. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) – March 2013
36. Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study
37. Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: Thrombin or factor-Xa inhibitors. Recommendations of the Working Group on perioperative haemostasis and the French Study Group on thrombosis and haemostasis
38. Induction of the fibrinolytic system by cartilage extract mediates its antiangiogenic effect in mouse glioma
39. La thrombophilie de l’hémogramme
40. French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding)
41. Outcomes for Inpatients with Normal Findings on Whole-leg Ultrasonography: A Prospective Study
42. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial
43. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach
44. Éducation thérapeutique des patients traités par anticoagulants oraux antivitamines K
45. Adjusting D-dimer to Lung Disease Extent to Exclude Pulmonary Embolism in COVID-19 Patients (Co-LEAD).
46. Development of a Bayesian estimation tool to determine the optimal duration of apixaban discontinuation before a high‐bleeding risk procedure.
47. Cardiovascular mortality and C-reactive protein in elderly patients beginning dialysis: reverse epidemiology?
48. A follow-up study of a genome-wide association scan identifies a susceptibility locus for venous thrombosis on chromosome 6p24.1
49. Antithrombotic therapy after infrainguinal bypass
50. Low-Molecular-Weight Heparin Prophylaxis of Deep Vein Thrombosis for Older Patients with Restricted Mobility: Propensity Analyses of Data from Two Multicentre, Cross-Sectional Studies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.